A Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of the Angiotensin II Antagonist Valsartan on Diastolic Function in Patients With Hypertension and Diastolic Dysfunction
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- Acronyms VALIDD
- 07 Nov 2011 Actual end date (June 2006) added as reported by ClinicalTrials.gov.
- 25 Mar 2007 Results data have been presented.
- 05 Nov 2005 New trial record.